Recovery after right liver surgery for liver cancer
Part of Cancer, Digestive system clinical trials.
This trial looks at how well patients do after surgery to remove the right half of the liver for a specific type of liver cancer. It helps doctors understand what leads to the best recovery after this operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your tumor is in the right half of the liver and has been confirmed as a specific type of liver cancer (hepatocellular carcinoma).
- You are having planned surgery (not an emergency).
- Your liver function is fairly good (Child-Pugh class A or B) and you are in good overall health (ASA class I, II, or III).
- You have not had previous upper abdominal surgery, and the cancer has not spread beyond the liver to other organs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks how patients recover after having part of their liver or bile ducts surgically removed at a specialized center. Researchers will review medical records and follow-ups to understand which patients do well and identify ways to improve care.
This trial looks at how well certain initial treatments (like targeted therapy, immunotherapy, or liver-directed procedures) work in people with liver cancer who have not had surgery yet. It aims to see if these treatments can shrink the tumor enough to allow removal later.
This trial tests a combination of liver-directed radiation, chemoembolization (TACE), and either a targeted therapy or immunotherapy for people with liver cancer that cannot be surgically removed and is limited to the right side of the liver. It aims to see if this approach is safe and helps control the cancer.
This trial tests a two-step liver surgery approach for people with advanced (not fully removable) liver cancer or end-stage liver disease, using chemotherapy first when applicable. The goal is to see if this staged plan can better control disease and allow safer surgery.
This trial tests a new way to control blood flow during laparoscopic liver surgery. It compares two methods to see which is safer and more effective for patients with certain liver conditions.
This trial is studying people with liver cancer (hepatocarcinoma) whose cancer returns (recurs) or never fully goes away (persists) after surgery. It looks at patterns after treatment at a specific study center, which may help guide better care for future patients.
Hear when a new Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.